Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Program    symbols : Alny    save search

Alnylam Announces 2023 Product and Pipeline Goals and Provides Program Updates at R&D Day
Published: 2022-12-15 (Crawled : 14:00) - biospace.com/
SNYNF | News | $94.0 -0.27% 0 twitter stocktwits trandingview |
Health Technology
| | O: -0.85% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 220K twitter stocktwits trandingview |
Health Technology
| | O: 0.04% H: 0.0% C: 0.0%
ALNY | $143.8 -1.55% -1.58% 50 twitter stocktwits trandingview |
Health Technology
| | O: -0.39% H: 0.0% C: -1.56%

day program
Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program
Published: 2022-06-25 (Crawled : 12:20) - globenewswire.com
GILD | $66.69 -0.58% 850K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
VIR | $7.97 -0.87% 8.5K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
ALNY | $143.8 -1.55% -1.58% 50 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

hepatitis program
Vir Biotechnology Announces New Data From the MARCH Hepatitis B Trial, Unveils New Hepatitis D Clinical Program and Highlights Broad Hepatitis Portfolio at Virtual Hepatitis Portfolio R&D Day
Published: 2022-04-27 (Crawled : 13:00) - globenewswire.com
VIR | $7.97 -0.87% 8.5K twitter stocktwits trandingview |
Health Technology
| | O: -3.68% H: 1.77% C: -2.91%
ALNY | $143.8 -1.55% -1.58% 50 twitter stocktwits trandingview |
Health Technology
| | O: -2.4% H: 1.24% C: -0.53%

day hepatitis program
RNAi Roundtable: CNS & Extrahepatic RNAi Pipeline Programs
Published: 2021-10-01 (Crawled : 18:00) - alnylam.com
ALNY | $143.8 -1.55% -1.58% 50 twitter stocktwits trandingview |
Health Technology
| | O: -0.06% H: 0.0% C: 0.0%

program
RNAi Roundtable: Liver-Directed RNAi Pipeline Programs
Published: 2021-09-20 (Crawled : 15:15) - alnylam.com
ALNY | $143.8 -1.55% -1.58% 50 twitter stocktwits trandingview |
Health Technology
| | O: -1.25% H: 0.1% C: -2.4%

liver program
Alnylam Announces New Advances in ATTR Amyloidosis Program
Published: 2021-05-11 (Crawled : 12:00) - biospace.com/
ALNY | $143.8 -1.55% -1.58% 50 twitter stocktwits trandingview |
Health Technology
| | O: -1.69% H: 5.46% C: 4.71%

program
Gainers vs Losers
50% 50%

Top 10 Gainers
CSSE 4 | $0.299 96.32% 7M twitter stocktwits trandingview |
Consumer Services

BRFH 4 | $1.99 80.91% 13M twitter stocktwits trandingview |
Manufacturing

BOF | $1.915 63.68% 620K twitter stocktwits trandingview |

AMST | $3.13 56.5% 500K twitter stocktwits trandingview |
Technology Services

ACON | $0.3595 24.83% 3.5M twitter stocktwits trandingview |
n/a

ILAG | $0.669 23.89% 13M twitter stocktwits trandingview |

CDTX | News | $14.57 18.55% 330K twitter stocktwits trandingview |
Health Technology

ULBI M | $10.12 15.92% 120K twitter stocktwits trandingview |
Producer Manufacturing

LRHC | $1.79 11.88% 3K twitter stocktwits trandingview |
n/a

AIXI | $1.34 8.94% 42K twitter stocktwits trandingview |
n/a


Your saved searches
Save your searches and get alerts when important news are released.